Cineverse (CNVS) investor relations material

Executive summary

• Revenue grew 22% year-over-year to $11.1 million, driven by streaming, digital, theatrical, and physical sales, with improved operating margins.

• Net loss attributable to common stockholders was $3.6 million, or $(0.21) per share, compared to $3.2 million, or $(0.20) per share, in the prior year quarter.

• Adjusted EBITDA was $(2.1) million, reflecting higher SG&A and content investments.

• Strategic investments in SG&A and marketing supported an expanded theatrical slate and technology initiatives, with expected returns in the next quarters.

• Launched new ventures, including a 50/50 joint venture for MicroCo targeting the $10 billion microseries market, and acquired high-potential IP such as Air Bud Returns.

Financial highlights

• Streaming and digital revenues rose 18% to $9.1 million; total revenue reached $11.1 million, up 22% year-over-year.

• Gross margin improved to 57%, up from 51% prior year, despite higher direct operating expenses.

• SG&A expenses increased 36% to $9.0 million, mainly due to compensation, marketing, and legal costs.

• Cash and equivalents stood at $2.0 million, with $8.9 million available under a $12.5 million line of credit as of June 30, 2025.

• Working capital was $(0.3) million, down from $3.6 million at the prior year quarter end.

Outlook and guidance

• Management expects strong top and bottom line results for the remainder of the fiscal year as investments begin to yield returns.

• Upcoming wide releases include The Toxic Avenger Unrated, Silent Night, Deadly Night, Return to Silent Hill, and Air Bud Returns.

• Projected 35% growth in international viewing hours, driven by FAST channel expansion.

• Cash and credit availability are expected to support operations for at least twelve months.